secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMED CORP (CHE)
CIK:        0000019584
Form:       8-K
Filed at:   2025-10-28T23:59:59+00:00
Accession:  0000019584-25-000004
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemed Q3 GAAP EPS falls 10.8% to $4.46; adjusted EPS down 6.6% to $5.27
------------------------------------------------------------------------

- Consolidated revenue $624.9M (+3.1% YoY); VITAS revenue $407.7M (+4.2%), Roto-Rooter $217.2M (+1.1%).
- VITAS ADC 22,327 (+2.5%); admissions up 5.6%; Medicare Cap accrual $6.1M vs $2.2M prior year.
- Roto-Rooter adjusted EBITDA $49.4M (-12.4%); margin 22.7% vs 26.2% prior year.
- Chemed: $129.8M cash, no debt; repurchased 407,500 shares for $180.8M during quarter.
- Reiterates FY2025 adjusted EPS guidance $22.00-$22.30, assuming no Florida Medicare Cap.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/19584/000001958425000004/0000019584-25-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/19584/000001958425000004/che-20251028x8k.htm
  HTML page:      https://secwatch.observer/filing/0000019584-25-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer